SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 77.60 |
| Enterprise Value ($M) | -16.83 |
| Book Value ($M) | 95.27 |
| Book Value / Share | 1.06 |
| Price / Book | 0.81 |
| NCAV ($M) | 95.04 |
| NCAV / Share | 1.06 |
| Price / NCAV | 0.82 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.28 |
| Return on Assets (ROA) | -2.42 |
| Return on Equity (ROE) | -3.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 35.62 |
| Current Ratio | 35.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 97.90 |
| Assets | 98.13 |
| Liabilities | 2.86 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -29.92 |
| Net Income | -26.73 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -14.56 |
| Cash from Investing | -14.76 |
| Cash from Financing | 109.29 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avidity Partners Management LP | 9.90 | 0.00 | |
| 13G/A | Opaleye Management Inc. | 0.00 | -100.00 | |
| 13G/A | Great Point Partners Llc | 6.25 | -32.46 | |
| 13G/A | Blue Owl Capital Holdings LP | 8.48 | 17.49 | |
| 13G/A | Lehr Martin A. | 2.10 | 9.86 | |
| 13G | Franklin Resources Inc | 5.30 | ||
| 13G | MPM Oncology Impact Management LP | 16.40 | ||
| 13G/A | Hudson Bay Capital Management LP | 1.32 | 0.00 | |
| 13G | Nextech Crossover I GP S.a r.l. | 9.90 | ||
| 13G | Deep Track Capital, LP | 9.89 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 7,839 | 39,847 | 19.67 | |
| 4,013 | 75,600 | 5.31 | |
| 19,797 | 61,196 | 32.35 | |
| 8,878 | 80,026 | 11.09 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CLRB – Cellectar Biosciences, Inc. | CMPX – Compass Therapeutics, Inc. |
| CNSP – CNS Pharmaceuticals, Inc. | COCP – Cocrystal Pharma, Inc. |
| COEP – Coeptis Therapeutics Holdings, Inc. |
Financial data and stock pages provided by
Fintel.io